Ophthotech Corporation (NASDAQ:OPHT) reported Q2 2017 earnings this Morning, coming in at ($0.62) per share, beating Wall Street’s estimates of ($1.04) per Share. Revenue for the quarter came in at $1.66 million beating analyst estimates of $1.38 million
Analyst Coverage For Ophthotech Corporation (NASDAQ:OPHT)
These are 12 Hold Ratings .
The current consensus rating for Ophthotech Corporation (NASDAQ:OPHT) is Hold (Score: 2.00) with a consensus target price of $59.11 , a potential (2,139.06% upside)Recent Insider Trading for Ophthotech Corporation (NASDAQ:OPHT)
- On 7/5/2017 Barbara A Wood, SVP, sold 5,119 with an average share price of $2.58 per share and the total transaction amounting to $13,207.02.
- On 7/5/2017 David Francis Carroll, CFO, sold 3,284 with an average share price of $2.58 per share and the total transaction amounting to $8,472.72.
- On 7/5/2017 David R Guyer, Chairman, sold 17,678 with an average share price of $2.58 per share and the total transaction amounting to $45,609.24.
- On 7/5/2017 Glenn Sblendorio, CEO, sold 7,828 with an average share price of $2.58 per share and the total transaction amounting to $20,196.24.
- On 6/13/2017 David E Redlick, Director, sold 700 with an average share price of $2.52 per share and the total transaction amounting to $1,764.00.
- On 4/3/2017 Glenn Sblendorio, CFO, sold 7,388 with an average share price of $3.56 per share and the total transaction amounting to $26,301.28.
Recent Trading for Ophthotech Corporation (NASDAQ:OPHT) Shares of Ophthotech Corporation closed the previous trading session at 2.80 up +0.16 6.21% with 327,640 shares trading hands.